FDA Adverse Event Malfunction Summary report: N

MEDRAD VERIS MR VITAL SIGNS MONITOR

MDR report key: 3217127 · Received July 3, 2013

Report

Report Number
2520313-2013-00036
Event Type
Malfunction
Date Received
July 3, 2013
Date of Event
June 11, 2013
Report Date
June 11, 2013
Manufacturer
MEDRAD
Product Code
MHX
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

BAYER R & I SERVICE REPLACED THE CHARGER AND NOTED THAT IT HAD SHORTED DUE TO MELTED WIRES IN THE POWER CABLE. THE SUPPLY CABLE WAS DISCARDED BY BIOMEDICAL PERSONNEL AT THE SITE AND THEREFORE, UNAVAILABLE FOR OUR INVESTIGATION. BAYER S & I PRODUCT ANALYSIS REVIEWED THE INFORMATION IN THE COMPLAINT RECORD AND DETERMINED THIS TO BE A RUNAWAY CURRENT CONDITION THAT IS INITIATED BY A SHORT CIRCUIT WITHIN THE DC POWER CABLE. A SUBSEQUENT INVESTIGATION OF SIMILAR COMPLAINTS CONCLUDED THAT WHEN CERTAIN COMBINATIONS OF CONDUCTORS SHORT TOGETHER AT THE CABLE END FARTHEST FROM THE POWER SUPPLY, THIS CAN CREATE A CONDUCTION PATHWAY THAT THE POWER SUPPLY DOES NOT RECOGNIZE AS A SHORT CIRCUIT AND SHUT DOWN. CONSEQUENTLY, THE POWER SUPPLY CONTINUES TO ENERGIZE THE CABLE WHICH CAN LEAD TO LOCALIZED HEATING AND MELTING OF THE POWER CABLE. ON (B)(6) 2013, BAYER HEALTHCARE DISTRIBUTED A FIELD SAFETY NOTICE RECALLING ALL 25-FOOT DC POWER CABLES SHIPPED WITH MEDRAD VERIS MR VITAL SIGNS MONITORS, OR THOSE PROVIDED BY BAYER SERVICE. THESE POWER CABLES ARE BEING RECALLED DUE TO A LATENT DESIGN RELIABILITY ISSUE AND THE POTENTIAL FOR SHORTING WHICH CAN RESULT IN HEATING/MELTING OF THE CABLE JACKET.

Description of Event or Problem · 1

THE SITE REPORTED THE FOLLOWING: MONITOR WILL NOT STAY ON. THE VERIS MONITOR SYSTEM WAS CHECKED BY BIOMEDICAL ENGINEER AT THE SITE AND DETERMINED THAT THE CHARGER WAS CAUSING THE REPORTED SYMPTOM.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
304214 MEDRAD VERIS MR VITAL SIGNS MONITOR MONITOR, PHYSIOLOGICAL PATIENT MHX MEDRAD 3011996W

Patients

Seq Age Sex Outcome Treatment
1